Works by Iihara, Hirotoshi


Results: 54
    1

    Geriatric 8 score as a prognostic factor of the efficacy and safety of oxaliplatin-based chemotherapy in elderly patients with metastatic colorectal cancer.

    Published in:
    International Journal of Colorectal Disease, 2025, v. 40, n. 1, p. 1, doi. 10.1007/s00384-025-04923-9
    By:
    • Hara, Koki;
    • Chikaishi, Wakana;
    • Yamada, Yunami;
    • Fujii, Hironori;
    • Tajima, Jesse Yu;
    • Iihara, Hirotoshi;
    • Makiyama, Akitaka;
    • Watanabe, Daichi;
    • Ohata, Koichi;
    • Hirose, Chiemi;
    • Kobayashi, Ryo;
    • Suzuki, Akio;
    • Matsuhashi, Nobuhisa
    Publication type:
    Article
    2

    Proton Pump Inhibitors and Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Breast Cancer.

    Published in:
    Oncologist, 2024, v. 29, n. 6, p. e741, doi. 10.1093/oncolo/oyae015
    By:
    • Takahashi, Kaori;
    • Uozumi, Ryuji;
    • Mukohara, Toru;
    • Hayashida, Tetsu;
    • Iwabe, Midori;
    • Iihara, Hirotoshi;
    • Kusuhara-Mamishin, Kanako;
    • Kitagawa, Yuko;
    • Tsuchiya, Masami;
    • Kitahora, Mika;
    • Nagayama, Aiko;
    • Kosaka, Shinkichi;
    • Asano-Niwa, Yoshimi;
    • Seki, Tomoko;
    • Ohnuki, Koji;
    • Suzuki, Akio;
    • Ono, Fumiko;
    • Futamura, Manabu;
    • Kawazoe, Hitoshi;
    • Nakamura, Tomonori
    Publication type:
    Article
    3
    4

    Low‐Dose Olanzapine Plus Granisetron and Dexamethasone for Carboplatin‐Induced Nausea and Vomiting in Patients with Thoracic Malignancies: A Prospective Multicenter Phase II Trial.

    Published in:
    Oncologist, 2021, v. 26, n. 6, p. e1066, doi. 10.1002/onco.13772
    By:
    • Sakai, Chizuru;
    • Shimokawa, Mototsugu;
    • Iihara, Hirotoshi;
    • Fujita, Yukiyoshi;
    • Ikemura, Shinnosuke;
    • Hirose, Chiemi;
    • Kotake, Mie;
    • Funaguchi, Norihiko;
    • Gomyo, Takenobu;
    • Imai, Hisao;
    • Hakamata, Jun;
    • Kaito, Daizo;
    • Minato, Koichi;
    • Arai, Takahiro;
    • Kawazoe, Hitoshi;
    • Suzuki, Akio;
    • Ohno, Yasushi;
    • Okura, Hiroyuki
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Real-world data of the association between quality of life using the EuroQol 5 Dimension 5 Level utility value and adverse events for outpatient cancer chemotherapy.

    Published in:
    Supportive Care in Cancer, 2020, v. 28, n. 12, p. 5943, doi. 10.1007/s00520-020-05443-8
    By:
    • Hirose, Chiemi;
    • Fujii, Hironori;
    • Iihara, Hirotoshi;
    • Ishihara, Masashi;
    • Nawa-Nishigaki, Minako;
    • Kato-Hayashi, Hiroko;
    • Ohata, Koichi;
    • Sekiya, Kumiko;
    • Kitahora, Mika;
    • Matsuhashi, Nobuhisa;
    • Takahashi, Takao;
    • Okuda, Kumiko;
    • Naruse, Masayo;
    • Ishihara, Takuma;
    • Sugiyama, Tadashi;
    • Yoshida, Kazuhiro;
    • Suzuki, Akio
    Publication type:
    Article
    14
    15
    16

    Proposal for Classifying the Emetogenicity of Oral Anticancer Agents with a Focus on PARP Inhibitors: A Prospective, Observational, Multicenter Study (JASCC-CINV 2002).

    Published in:
    Journal of Cancer, 2024, v. 15, n. 6, p. 1487, doi. 10.7150/jca.91675
    By:
    • Senri Yamamoto;
    • Masami Tsuchiya;
    • Hirotoshi Iihara;
    • Yoh Hayasaki;
    • Kyoko Hori;
    • Yasuo Kumakura;
    • Daichi Watanabe;
    • Hideki Sakai;
    • Satoshi Nakagawa;
    • Akiko Kudoh;
    • Hajime Oishi;
    • Nobuhiro Kado;
    • Makiko Go;
    • Kota Mashima;
    • Takashi Uchida;
    • Moeka Yasue;
    • Akimitsu Maeda;
    • Kimihiro Nishino;
    • Koji Matsumoto;
    • Shinya Sato
    Publication type:
    Article
    17

    Doublet or Triplet Antiemetic Prophylaxis for Nausea and Vomiting Induced by Trastuzumab Deruxtecan: an Open-Label, Randomized, and Multicenter Exploratory Phase 2 Study.

    Published in:
    Journal of Cancer, 2023, v. 14, n. 14, p. 2644, doi. 10.7150/jca.87169
    By:
    • Hirotoshi Iihara;
    • Mototsugu Shimokawa;
    • Hiroko Bando;
    • Yoshimi Niwa;
    • Yutaka Mizuno;
    • Yoshihiro Kawaguchi;
    • Mika Kitahora;
    • Akari Murakami;
    • Masaaki Kawai;
    • Kazushige Ishida;
    • Makoto Takeuchi;
    • Kazuhiro Ishihara;
    • Tomokazu Iyoda;
    • Takumi Nakada;
    • Atsuko Ogiso;
    • Yasuyuki Kojima;
    • Fumiyoshi Kumagai;
    • Aya Sawa;
    • Ryutaro Mori;
    • Kosuke Higuchi
    Publication type:
    Article
    18

    Prognostic Model of Baseline Medications plus Neutrophil-to-lymphocyte Ratio in Patients with Advanced Non-small-cell Lung Cancer Receiving Immune Checkpoint Inhibitor plus Platinum Doublet: A Multicenter Retrospective Study.

    Published in:
    Journal of Cancer, 2023, v. 14, n. 5, p. 676, doi. 10.7150/jca.80517
    By:
    • Izumi Nasu;
    • Masahiro Kondo;
    • Ryuji Uozumi;
    • Shinya Takada;
    • Shuichi Nawata;
    • Hirotoshi Iihara;
    • Yohei Okumura;
    • Masashi Takemoto;
    • Kozo Mino;
    • Tadanori Sasaki;
    • Chiemi Hirose;
    • Tohru Aomori;
    • Rena Shimano;
    • Ken Maeno;
    • Satoshi Oizumi;
    • Sojiro Kusumoto;
    • Yasushi Ohno;
    • Shinnosuke Ikemura;
    • Daiya Takai;
    • Azusa Hara
    Publication type:
    Article
    19

    Association between the Co-administration of Histamine H<sub>2</sub> Receptor Antagonists and the Effectiveness of Capecitabine in Patients with Colorectal Cancer: Propensity Score Analysis.

    Published in:
    Journal of Cancer, 2022, v. 13, n. 10, p. 3073, doi. 10.7150/jca.73385
    By:
    • Tomoko Yamazaki;
    • Ryuji Uozumi;
    • Hitoshi Kawazoe;
    • Yoshiko Kitazume;
    • Hirotoshi Iihara;
    • Hironori Fujii;
    • Masaya Takahashi;
    • Takahiro Arai;
    • Yasushi Murachi;
    • Yumiko Sato;
    • Takahiro Mikami;
    • Koji Hashiguchi;
    • Tomoe Yoshizawa;
    • Katsuyuki Takahashi;
    • Yukiyoshi Fujita;
    • Yuki Hosokawa;
    • Issei Morozumi;
    • Masami Tsuchiya;
    • Atsushi Yokoyama;
    • Hironobu Hashimoto
    Publication type:
    Article
    20

    Effectiveness of countermeasure for polypharmacy by multidisciplinary team review in patients with diabetes mellitus.

    Published in:
    Journal of Diabetes Investigation, 2023, v. 14, n. 10, p. 1202, doi. 10.1111/jdi.14046
    By:
    • Nishida, Shohei;
    • Kato, Takehiro;
    • Hayashi, Yuichi;
    • Yamada, Shoya;
    • Fujii, Hironori;
    • Yamada, Michi;
    • Asai, Nao;
    • Shimizu, Shinya;
    • Niwa, Takashi;
    • Iihara, Hirotoshi;
    • Kubota, Sodai;
    • Sakai, Mayu;
    • Takahashi, Yoshihiro;
    • Takao, Ken;
    • Mizuno, Masami;
    • Hirota, Takuo;
    • Kobayashi, Ryo;
    • Horikawa, Yukio;
    • Yabe, Daisuke;
    • Suzuki, Akio
    Publication type:
    Article
    21

    Questionnaire survey to identify meal habits which influence adherence to oral 5‐aminosalicylic acid regimens in patients with ulcerative colitis.

    Published in:
    Journal of Pharmacy Practice & Research, 2021, v. 51, n. 5, p. 374, doi. 10.1002/jppr.1712
    By:
    • Suzuki, Keiko;
    • Fujii, Hironori;
    • Yamauchi, Tomoyo;
    • Kato‐Hayashi, Hiroko;
    • Ishihara, Masashi;
    • Iihara, Hirotoshi;
    • Hirose, Chiemi;
    • Nishida, Shohei;
    • Funato, Miyui;
    • Kobayashi, Ryo;
    • Yasuda, Koji;
    • Ino, Yoko;
    • Tamaki, Hirofumi;
    • Yamashita, Shuji;
    • Iguchi, Kazuhiro;
    • Noguchi, Yoshihiro;
    • Teramachi, Hitomi;
    • Takada, Jun;
    • Kubota, Masaya;
    • Ibuka, Takashi
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28

    Effects of adding a neurokinin-1 receptor antagonist to 5 mg olanzapine, a 5-hydroxytryptamine-3 receptor antagonist, and dexamethasone for preventing carboplatin-induced nausea and vomiting: a propensity score-matched analysis.

    Published in:
    2022
    By:
    • Yamamoto, Senri;
    • Iihara, Hirotoshi;
    • Uozumi, Ryuji;
    • Kawazoe, Hitoshi;
    • Tanaka, Kazuki;
    • Fujita, Yukiyoshi;
    • Abe, Masakazu;
    • Imai, Hisao;
    • Karayama, Masato;
    • Hayasaki, Yoh;
    • Hirose, Chiemi;
    • Suda, Takafumi;
    • Nakamura, Kazuto;
    • Suzuki, Akio;
    • Ohno, Yasushi;
    • Morishige, Ken-ichirou;
    • Inui, Naoki
    Publication type:
    journal article
    29

    Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015  Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 1, p. 1, doi. 10.1007/s10147-020-01818-3
    By:
    • Aogi, Kenjiro;
    • Takeuchi, Hideki;
    • Saeki, Toshiaki;
    • Aiba, Keisuke;
    • Tamura, Kazuo;
    • Iino, Keiko;
    • Imamura, Chiyo K.;
    • Okita, Kenji;
    • Kagami, Yoshikazu;
    • Tanaka, Ryuhei;
    • Nakagawa, Kazuhiko;
    • Fujii, Hirofumi;
    • Boku, Narikazu;
    • Wada, Makoto;
    • Akechi, Tatsuo;
    • Iihara, Hirotoshi;
    • Ohtani, Shoichiro;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Kim, Yong-Il
    Publication type:
    Article
    30
    31
    32

    Dexamethasone-sparing on days 2–4 with combined palonosetron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial).

    Published in:
    British Journal of Cancer, 2024, v. 130, n. 2, p. 224, doi. 10.1038/s41416-023-02493-7
    By:
    • Minatogawa, Hiroko;
    • Izawa, Naoki;
    • Shimomura, Kazuhiro;
    • Arioka, Hitoshi;
    • Iihara, Hirotoshi;
    • Sugawara, Mitsuhiro;
    • Morita, Hajime;
    • Mochizuki, Ayako;
    • Nawata, Shuichi;
    • Mishima, Keisuke;
    • Tsuboya, Ayako;
    • Miyaji, Tempei;
    • Honda, Kazunori;
    • Yokomizo, Ayako;
    • Hashimoto, Naoya;
    • Yanagihara, Takeshi;
    • Endo, Junki;
    • Kawaguchi, Takashi;
    • Furuya, Naoki;
    • Sone, Yumiko
    Publication type:
    Article
    33
    34
    35

    Clinical benefits of adding olanzapine to 5-HT<sub>3</sub> receptor antagonist, NK<sub>1</sub> receptor antagonist, and dexamethasone for the prevention of nausea and vomiting in highly emetogenic chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology

    Published in:
    2025
    By:
    • Murakami, Michiyasu;
    • Miyata, Yoshiharu;
    • Nakashima, Kazuhisa;
    • Abe, Masakazu;
    • Nishimura, Junichi;
    • Wada, Makoto;
    • Iino, Keiko;
    • Akechi, Tatsuo;
    • Iihara, Hirotoshi;
    • Imamura, Chiyo K.;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Kim, Yong-il;
    • Sasaki, Hidenori;
    • Satomi, Eriko;
    • Takeda, Masayuki;
    • Tanaka, Ryuhei;
    • Nakamura, Naoki;
    • Noda, Mayumi;
    • Hayashi, Kazumi
    Publication type:
    Literature Review
    36

    Efficacy and safety of multi-day antiemetic treatment for patients undergoing multi-day chemotherapy: a systematic review of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology.

    Published in:
    2025
    By:
    • Nakashima, Kazuhisa;
    • Harashima, Saki;
    • Kaneko, Rena;
    • Tanaka, Ryuhei;
    • Abe, Masakazu;
    • Wada, Makoto;
    • Iino, Keiko;
    • Akechi, Tatsuo;
    • Iihara, Hirotoshi;
    • Imamura, Chiyo K.;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Kim, Yong-il;
    • Satomi, Eriko;
    • Takeda, Masayuki;
    • Nakajima, Takako Eguchi;
    • Nakamura, Naoki;
    • Nishimura, Junichi;
    • Noda, Mayumi;
    • Hayashi, Kazumi
    Publication type:
    Literature Review
    37

    Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy: a systematic review and meta-analysis of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 12, p. 1785, doi. 10.1007/s10147-024-02643-8
    By:
    • Nakashima, Kazuhisa;
    • Yokomizo, Ayako;
    • Murakami, Michiyasu;
    • Okita, Kenji;
    • Wada, Makoto;
    • Iino, Keiko;
    • Akechi, Tatsuo;
    • Iihara, Hirotoshi;
    • Imamura, Chiyo K.;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Kim, Yong-il;
    • Sasaki, Hidenori;
    • Satomi, Eriko;
    • Takeda, Masayuki;
    • Tanaka, Ryuhei;
    • Nakajima, Takako Eguchi;
    • Nakamura, Naoki;
    • Nishimura, Junichi;
    • Noda, Mayumi
    Publication type:
    Article
    38

    Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with highly emetogenic risk antineoplastic agents: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 11, p. 1632, doi. 10.1007/s10147-024-02624-x
    By:
    • Yokomizo, Ayako;
    • Nakashima, Kazuhisa;
    • Iba, Arisa;
    • Okita, Kenji;
    • Wada, Makoto;
    • Iino, Keiko;
    • Akechi, Tatsuo;
    • Iihara, Hirotoshi;
    • Imamura, Chiyo K.;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Kim, Yong-Il;
    • Sasaki, Hidenori;
    • Satomi, Eriko;
    • Takeda, Masayuki;
    • Tanaka, Ryuhei;
    • Nakajima, Takako Eguchi;
    • Nakamura, Naoki;
    • Nishimura, Junichi;
    • Noda, Mayumi
    Publication type:
    Article
    39

    Non-pharmacological treatments for anticipatory nausea and vomiting during chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 889, doi. 10.1007/s10147-024-02536-w
    By:
    • Kobayashi, Masamitsu;
    • Kako, Jun;
    • Iba, Arisa;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Abe, Masakazu;
    • Wada, Makoto;
    • Akechi, Tatsuo;
    • Iihara, Hirotoshi;
    • Imamura, Chiyo K.;
    • Kim, Yong-Il;
    • Sasaki, Hidenori;
    • Satomi, Eriko;
    • Takeda, Masayuki;
    • Tanaka, Ryuhei;
    • Nakajima, Takako Eguchi;
    • Nakamura, Naoki;
    • Nishimura, Junichi;
    • Noda, Mayumi;
    • Hayashi, Kazumi
    Publication type:
    Article
    40

    2023 Japan Society of clinical oncology clinical practice guidelines update for antiemesis.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 873, doi. 10.1007/s10147-024-02535-x
    By:
    • Iihara, Hirotoshi;
    • Abe, Masakazu;
    • Wada, Makoto;
    • Iino, Keiko;
    • Akechi, Tatsuo;
    • Imamura, Chiyo K.;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Kim, Yong-Il;
    • Sasaki, Hidenori;
    • Satomi, Eriko;
    • Takeda, Masayuki;
    • Tanaka, Ryuhei;
    • Nakajima, Takako Eguchi;
    • Nakamura, Naoki;
    • Nishimura, Junichi;
    • Noda, Mayumi;
    • Hayashi, Kazumi;
    • Higashi, Takahiro;
    • Boku, Narikazu
    Publication type:
    Article
    41
    42

    Cancer cachexia as a determinant of efficacy of first-line pembrolizumab in patients with advanced non-small cell lung cancer.

    Published in:
    Molecular & Clinical Oncology, 2022, v. 16, n. 4, p. N.PAG, doi. 10.3892/mco.2022.2524
    By:
    • Fujii, Hironori;
    • Araki, Ayumu;
    • Iihara, Hirotoshi;
    • Kaito, Daizo;
    • Hirose, Chiemi;
    • Kinomura, Motohiko;
    • Yamazaki, Mizuki;
    • Endo, Junki;
    • Inui, Toshiya;
    • Yanase, Komei;
    • Sasaki, Yuka;
    • Gomyo, Takenobu;
    • Sakai, Chizuru;
    • Kawae, Daisuke;
    • Kitamura, Yu;
    • Fukui, Masachika;
    • Kobayashi, Ryo;
    • Ohno, Yasushi;
    • Suzuki, Akio
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50

    Pharmaceutical intervention for adverse events improves quality of life in patients with cancer undergoing outpatient chemotherapy.

    Published in:
    Journal of Pharmaceutical Health Care & Sciences, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40780-022-00239-w
    By:
    • Fujii, Hironori;
    • Ueda, Yukino;
    • Hirose, Chiemi;
    • Ohata, Koichi;
    • Sekiya, Kumiko;
    • Kitahora, Mika;
    • Sadaka, Shiori;
    • Yamamoto, Senri;
    • Watanabe, Daichi;
    • Kato-Hayashi, Hiroko;
    • Iihara, Hirotoshi;
    • Kobayashi, Ryo;
    • Kaburaki, Miho;
    • Matsuhashi, Nobuhisa;
    • Takahashi, Takao;
    • Makiyama, Akitaka;
    • Yoshida, Kazuhiro;
    • Hayashi, Hideki;
    • Suzuki, Akio
    Publication type:
    Article